SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-038622
Filing Date
2020-08-10
Accepted
2020-08-10 07:50:32
Documents
66
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q logc-10q_20200630.htm   iXBRL 10-Q 1775744
2 EX-10.1 logc-ex101_43.htm EX-10.1 46113
3 EX-31.1 logc-ex311_8.htm EX-31.1 18752
4 EX-31.2 logc-ex312_6.htm EX-31.2 18513
5 EX-32.1 logc-ex321_7.htm EX-32.1 7612
  Complete submission text file 0001564590-20-038622.txt   6185156

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA logc-20200630.xsd EX-101.SCH 39460
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE logc-20200630_cal.xml EX-101.CAL 49144
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE logc-20200630_def.xml EX-101.DEF 106450
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20200630_lab.xml EX-101.LAB 324590
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20200630_pre.xml EX-101.PRE 244283
11 EXTRACTED XBRL INSTANCE DOCUMENT logc-10q_20200630_htm.xml XML 1053627
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38707 | Film No.: 201087146
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences